Actuate Therapeutics Inc

NASDAQ:ACTU

Biotechnology

Healthcare
$2.09 +2.96%

+$0.06 today

Market cap
$50.01M
Beta
0.53
P/E (TTM)
-2.3
EPS (TTM)
-$0.92
52W Low $1.58High $9.22

Volume 0.03M

Average 0.16M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$19.21M

FY 2025 · Annual

Investing Cash Flow

$0.00

FY 2025 · Annual

Financing Cash Flow

$23.72M

FY 2025 · Annual

-13.8% YoY

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(20.16M)(24.74M)(27.29M)(22.23M)
Depreciation & Amortization0000
Deferred Income Tax0000
Stock-Based Compensation654.07K423.54K2M6.05M
Change in Working Capital1.73M2.57M1.1M(3.05M)
Accounts Receivables0000
Inventory0000
Accounts Payables586.26K1.29M(1.5M)(512.54K)
Other Working Capital1.15M1.28M2.6M(2.53M)
Other Non-Cash Items(20.38K)123.46K2.35M20.25K
Operating Cash Flow(17.79M)(21.63M)(21.84M)(19.21M)
Capital Expenditures0000
Acquisitions (Net)0000
Purchases of Investments0000
Sales of Investments0000
Other Investing Activities0000
Investing Cash Flow0000
Debt Repayment005.5M0
Common Stock Issued0023.96M24.03M
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities00(1.93M)(302.83K)
Financing Cash Flow19.26M4.13M27.53M23.72M
Effect of Forex Changes0000
Net Change in Cash1.46M(17.49M)5.68M4.52M
Free Cash Flow(17.79M)(21.63M)(21.84M)(19.21M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$22.2M
+ D&A$0
+ Stock-Based Comp$6.0M
+ Deferred Tax$0
- Working Capital-$3.0M
+ Other Non-Cash$20.3K
= Operating Cash Flow-$19.2M
- Capex$0
= Free Cash Flow-$19.2M

Analysis

FY2025 free cash flow is -$19.2M. FCF conversion is 86.4% of net income. Operating cash flow was -$19.2M, with capex of $0. The largest bridge item is Stock-Based Comp at $6.0M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipMay 22, 2026
4Statement of changes in beneficial ownershipMay 22, 2026
4Statement of changes in beneficial ownershipMay 22, 2026
8-KCurrent reportMay 22, 2026
4Statement of changes in beneficial ownershipMay 22, 2026

Does ACTU generate free cash flow?

Actuate Therapeutics Inc (ACTU) generated -$19.21M of free cash flow in fiscal 2025.

How much operating cash flow does ACTU produce?

Operating cash flow was -$19.21M, before capital expenditures of $0.00.